Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
November 1, 2000The Journal of Clinical Endocrinology & MetabolismOpen Access

Serum Levels of Insulin-Like Growth Factor I (IGF-I), IGF-II, IGF-Binding Protein-3, and Prostate-Specific Antigen as Predictors of Clinical Prostate Cancer

View Full Paper
Ask AI
Bookmark
Share

Authors

SHS. Mitchell HarmanPhoenix VA Health Care SystemEME. Jeffrey MetterUniversity of Tennessee Health Science CenterMBMarc R. BlackmanBoston University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Harman et al. (2000) studied this question.

synapsesocial.com/papers/6a747d2b8d2049c8dd03273chttps://doi.org/10.1210/jcem.85.11.6990
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Secretion of insulin-like growth factors and their binding proteins by human normal and hyperplastic prostatic cells in primary culture.1996 · 48 citations
  2. 2Human Kallikrein 2 (hK2) and Prostate-Specific Antigen (PSA): Two Closely Related, but Distinct, Kallikreins in the Prostate1998 · 303 citations
  3. 3Editorial: The Possible Autocrine/Paracrine and Endocrine Roles of Insulin-Like Growth Factors of Human Tumors1990 · 229 citations
  4. 4DIFFERENTIAL EXPRESSION OF INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS IN HIGH VERSUS LOW GLEASON SCORE PROSTATE CANCER1998 · 75 citations